Godavari Drugs Limited (GODAVARI.BO)
- Previous Close
90.00 - Open
90.21 - Bid --
- Ask 91.14 x --
- Day's Range
90.00 - 93.50 - 52 Week Range
79.00 - 118.95 - Volume
5,570 - Avg. Volume
5,704 - Market Cap (intraday)
677.745M - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
112.50 - EPS (TTM)
0.80 - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan license and contract manufacturing services for API's and drug intermediates. The company serves the life science industry. Godavari Drugs Limited was incorporated in 1987 and is based in Secunderabad, India.
godavaridrugs.com111
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: GODAVARI.BO
View MorePerformance Overview: GODAVARI.BO
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GODAVARI.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GODAVARI.BO
View MoreValuation Measures
Market Cap
677.75M
Enterprise Value
1.19B
Trailing P/E
112.50
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.54
Price/Book (mrq)
1.63
Enterprise Value/Revenue
0.94
Enterprise Value/EBITDA
9.14
Financial Highlights
Profitability and Income Statement
Profit Margin
4.85%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.27B
Net Income Avi to Common (ttm)
61.49M
Diluted EPS (ttm)
0.80
Balance Sheet and Cash Flow
Total Cash (mrq)
29.78M
Total Debt/Equity (mrq)
141.13%
Levered Free Cash Flow (ttm)
--